nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0486	0.051	CcSEcCtD
Vardenafil—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0407	0.0426	CcSEcCtD
Vardenafil—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0311	0.0326	CcSEcCtD
Vardenafil—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0289	0.0303	CcSEcCtD
Vardenafil—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0272	0.0286	CcSEcCtD
Vardenafil—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0248	CcSEcCtD
Vardenafil—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0205	CcSEcCtD
Vardenafil—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0188	CcSEcCtD
Vardenafil—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.017	0.0179	CcSEcCtD
Vardenafil—Injury—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0177	CcSEcCtD
Vardenafil—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0174	CcSEcCtD
Vardenafil—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0165	0.0172	CcSEcCtD
Vardenafil—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0172	CcSEcCtD
Vardenafil—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.015	0.0157	CcSEcCtD
Vardenafil—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0152	CcSEcCtD
Vardenafil—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0143	0.015	CcSEcCtD
Vardenafil—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0149	CcSEcCtD
Vardenafil—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0149	CcSEcCtD
Vardenafil—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.014	0.0147	CcSEcCtD
Vardenafil—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.014	0.0147	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.014	0.0147	CcSEcCtD
Vardenafil—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0144	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0144	CcSEcCtD
Vardenafil—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0141	CcSEcCtD
Vardenafil—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0141	CcSEcCtD
Vardenafil—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0137	CcSEcCtD
Vardenafil—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0128	CcSEcCtD
Vardenafil—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0124	CcSEcCtD
Vardenafil—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0123	CcSEcCtD
Vardenafil—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0122	CcSEcCtD
Vardenafil—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0115	0.012	CcSEcCtD
Vardenafil—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0114	0.012	CcSEcCtD
Vardenafil—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0118	CcSEcCtD
Vardenafil—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0118	CcSEcCtD
Vardenafil—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0113	CcSEcCtD
Vardenafil—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0112	CcSEcCtD
Vardenafil—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0112	CcSEcCtD
Vardenafil—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0108	CcSEcCtD
Vardenafil—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.01	0.0105	CcSEcCtD
Vardenafil—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0104	CcSEcCtD
Vardenafil—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00935	0.0098	CcSEcCtD
Vardenafil—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00904	0.00948	CcSEcCtD
Vardenafil—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00899	0.00942	CcSEcCtD
Vardenafil—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00924	CcSEcCtD
Vardenafil—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00867	0.00909	CcSEcCtD
Vardenafil—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00854	0.00895	CcSEcCtD
Vardenafil—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00843	0.00884	CcSEcCtD
Vardenafil—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0088	CcSEcCtD
Vardenafil—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00879	CcSEcCtD
Vardenafil—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00866	CcSEcCtD
Vardenafil—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00822	0.00861	CcSEcCtD
Vardenafil—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00834	CcSEcCtD
Vardenafil—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00834	CcSEcCtD
Vardenafil—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00834	CcSEcCtD
Vardenafil—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00793	0.00831	CcSEcCtD
Vardenafil—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00824	CcSEcCtD
Vardenafil—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00816	CcSEcCtD
Vardenafil—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00763	0.008	CcSEcCtD
Vardenafil—Shock—Hydrochlorothiazide—nephrolithiasis	0.00751	0.00787	CcSEcCtD
Vardenafil—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00745	0.00781	CcSEcCtD
Vardenafil—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00738	0.00773	CcSEcCtD
Vardenafil—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00713	0.00747	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00729	CcSEcCtD
Vardenafil—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00723	CcSEcCtD
Vardenafil—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00718	CcSEcCtD
Vardenafil—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0068	0.00713	CcSEcCtD
Vardenafil—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00678	0.00711	CcSEcCtD
Vardenafil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00704	CcSEcCtD
Vardenafil—Pain—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00684	CcSEcCtD
Vardenafil—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00629	0.00659	CcSEcCtD
Vardenafil—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00654	CcSEcCtD
Vardenafil—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00632	CcSEcCtD
Vardenafil—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00589	CcSEcCtD
Vardenafil—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00574	CcSEcCtD
Vardenafil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00566	CcSEcCtD
Vardenafil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00547	CcSEcCtD
Vardenafil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00529	CcSEcCtD
Vardenafil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00508	CcSEcCtD
Vardenafil—Rash—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00504	CcSEcCtD
Vardenafil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00504	CcSEcCtD
Vardenafil—Headache—Hydrochlorothiazide—nephrolithiasis	0.00478	0.00501	CcSEcCtD
Vardenafil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00475	CcSEcCtD
Vardenafil—PDE11A—G alpha (s) signalling events—PTH—nephrolithiasis	0.00284	0.0618	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—PTH—nephrolithiasis	0.00253	0.0551	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—SLC7A9—nephrolithiasis	0.00139	0.0303	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—DGKH—nephrolithiasis	0.00139	0.0303	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—RGS14—nephrolithiasis	0.0013	0.0284	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—PTH—nephrolithiasis	0.00128	0.0279	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SLC7A9—nephrolithiasis	0.00124	0.027	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—DGKH—nephrolithiasis	0.00124	0.027	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—DGKH—nephrolithiasis	0.00124	0.027	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SLC7A9—nephrolithiasis	0.00124	0.027	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—RGS14—nephrolithiasis	0.00118	0.0258	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00116	0.0253	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—RGS14—nephrolithiasis	0.00106	0.023	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00088	0.0192	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADCY10—nephrolithiasis	0.000822	0.0179	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—DGKH—nephrolithiasis	0.0008	0.0174	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000785	0.0171	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADCY10—nephrolithiasis	0.000752	0.0164	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADCY10—nephrolithiasis	0.000733	0.016	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—DGKH—nephrolithiasis	0.000713	0.0155	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RGS14—nephrolithiasis	0.000699	0.0152	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SLC26A1—nephrolithiasis	0.000692	0.0151	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000667	0.0145	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RGS14—nephrolithiasis	0.00064	0.0139	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000637	0.0139	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SLC7A9—nephrolithiasis	0.000629	0.0137	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—DGKH—nephrolithiasis	0.000629	0.0137	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RGS14—nephrolithiasis	0.000623	0.0136	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ATP6V0A4—nephrolithiasis	0.000617	0.0134	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000589	0.0128	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—PTH—nephrolithiasis	0.000582	0.0127	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000578	0.0126	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000567	0.0124	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000535	0.0116	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PTH—nephrolithiasis	0.000529	0.0115	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PTH—nephrolithiasis	0.000519	0.0113	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000515	0.0112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—SPP1—nephrolithiasis	0.000473	0.0103	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DGKH—nephrolithiasis	0.000472	0.0103	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000472	0.0103	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PTH—nephrolithiasis	0.000471	0.0103	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DGKH—nephrolithiasis	0.000432	0.00941	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000432	0.00941	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000421	0.00917	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DGKH—nephrolithiasis	0.000421	0.00917	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000398	0.00866	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000371	0.00809	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000361	0.00786	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SLC26A1—nephrolithiasis	0.000342	0.00744	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CHRM3—nephrolithiasis	0.000341	0.00744	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RGS14—nephrolithiasis	0.000316	0.00688	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTH—nephrolithiasis	0.000312	0.0068	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CHRM3—nephrolithiasis	0.000312	0.0068	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00031	0.00675	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ATP6V0A4—nephrolithiasis	0.000305	0.00663	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CHRM3—nephrolithiasis	0.000304	0.00663	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000288	0.00626	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTH—nephrolithiasis	0.000286	0.00622	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTH—nephrolithiasis	0.000278	0.00606	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000263	0.00573	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000261	0.00569	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTH—nephrolithiasis	0.000239	0.0052	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DGKH—nephrolithiasis	0.000213	0.00465	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000213	0.00465	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPP1—nephrolithiasis	0.000157	0.00341	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000154	0.00336	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.00015	0.00328	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPP1—nephrolithiasis	0.000143	0.00312	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTH—nephrolithiasis	0.000141	0.00307	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPP1—nephrolithiasis	0.00014	0.00304	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000134	0.00292	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000114	0.00248	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000114	0.00248	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AQP1—nephrolithiasis	8.12e-05	0.00177	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CHRM3—nephrolithiasis	7.35e-05	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—nephrolithiasis	7.08e-05	0.00154	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GRHPR—nephrolithiasis	6.99e-05	0.00152	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGXT—nephrolithiasis	6.23e-05	0.00136	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	5.3e-05	0.00115	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APRT—nephrolithiasis	5.3e-05	0.00115	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AQP1—nephrolithiasis	3.78e-05	0.000822	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CHRM3—nephrolithiasis	3.42e-05	0.000744	CbGpPWpGaD
